ATYR Q1 2020 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

$8M100.0% margin

Operating Income

$2M23.1% margin

Net Income

$2M21.7% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+5500.7%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$423,000

Balance Sheet

Total Assets

$54M

Total Liabilities

$12M

Stockholders' Equity

$42M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	$8M	$0	—
Operating Income	$2M	-$6M	+131.6%
Net Income	$2M	-$6M	+128.6%